Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The "ARS thing" showed excellent corporate governance because

The "ARS thing" showed excellent corporate governance because

posted on Jun 24, 2009 10:36PM

rather than the BoD just opting to place $15m into them, they took advice and guidance, then acted. It was a win-win situation, in my very humble opinion because they could sue if they didn't perform as stated and if they had, the returns would be greater than standard interest on the principal.

I would have been very concerned had the BoD, without external guidance, placed the sum in ARS, and that marks the difference.

Be well

Share
New Message
Please login to post a reply